Low or reduced? Semantics of the doses of new oral anticoagulants

Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Andrea Rubboli

Abstract

The four new oral anticoagulants (NOACs) dabigatran, rivaroxaban, apixaban and edoxaban are marketed in two doses each for the prevention of stroke and/or systemic thromboembolism in non-valvular atrial fibrillation (NVAF). The meaning and indications for use of the lower dose compared with the higher dose are, however, different between the thrombin-inhibitor dabigatran on the one hand and the activated factor X (Xa) inhibitors on the other. These differences stem from the different design of the registration studies where NOACs were compared with warfarin for the prevention of stroke and/or systemic thromboembolism in patients with NVAF. While in the RE-LY study, two different intensities of dabigatran treatment (150 and 110 mg bid) were evaluated in the same population, in the ROCKET AF, ARISTOTLE and ENGAGE AF-TIMI 48 studies two different populations were exposed to the same intensity of treatment, which was obtained however with the selective use of two doses of rivaroxaban (20/15 mg/die), apixaban (5/2.5 mg bid) and edoxaban (60/30 mg/die). With the two doses of dabigatran, efficacy and safety were proportional to treatment intensity. With the two doses of factor Xa inhibitors, the same effect on efficacy and safety was ...Continue Reading

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.